Credit Suisse’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3
| Closed | -$8 | – | 3559 |
|
|
2022
Q4 | $8 | Sell |
3
-437
| -99% | -$1.17K | ﹤0.01% | 3748 |
|
|
2022
Q3 | $2K | Buy |
+440
| New | +$2K | ﹤0.01% | 3729 |
|
|
2022
Q2 | – | Sell |
-61,043
| Closed | -$302K | – | 4170 |
|
|
2022
Q1 | $302K | Buy |
61,043
+15,841
| +35% | +$78.4K | ﹤0.01% | 3209 |
|
|
2021
Q4 | $316K | Buy |
45,202
+5,692
| +14% | +$39.8K | ﹤0.01% | 3282 |
|
|
2021
Q3 | $396K | Buy |
39,510
+2,233
| +6% | +$22.4K | ﹤0.01% | 3133 |
|
|
2021
Q2 | $529K | Sell |
37,277
-5,520
| -13% | -$78.3K | ﹤0.01% | 2990 |
|
|
2021
Q1 | $701K | Sell |
42,797
-22,158
| -34% | -$363K | ﹤0.01% | 2768 |
|
|
2020
Q4 | $1.34M | Buy |
+64,955
| New | +$1.34M | ﹤0.01% | 2381 |
|
|
2019
Q2 | – | Sell |
-14,437
| Closed | -$57K | – | 3477 |
|
|
2019
Q1 | $57K | Buy |
+14,437
| New | +$57K | ﹤0.01% | 3300 |
|
|
2018
Q3 | – | Sell |
-33,567
| Closed | -$226K | – | 3378 |
|
|
2018
Q2 | $226K | Sell |
33,567
-1,844
| -5% | -$12.4K | ﹤0.01% | 3265 |
|
|
2018
Q1 | $230K | Sell |
35,411
-889
| -2% | -$5.77K | ﹤0.01% | 3241 |
|
|
2017
Q4 | $161K | Sell |
36,300
-208,844
| -85% | -$926K | ﹤0.01% | 3286 |
|
|
2017
Q3 | $1.52M | Buy |
245,144
+229,349
| +1,452% | +$1.42M | ﹤0.01% | 2354 |
|
|
2017
Q2 | $146K | Buy |
15,795
+2,533
| +19% | +$23.4K | ﹤0.01% | 3289 |
|
|
2017
Q1 | $123K | Sell |
13,262
-39,921
| -75% | -$370K | ﹤0.01% | 3306 |
|
|
2016
Q4 | $446K | Buy |
53,183
+25,569
| +93% | +$214K | ﹤0.01% | 3146 |
|
|
2016
Q3 | $189K | Buy |
27,614
+10,163
| +58% | +$69.6K | ﹤0.01% | 3485 |
|
|
2016
Q2 | $86K | Buy |
+17,451
| New | +$86K | ﹤0.01% | 3775 |
|
|
2015
Q3 | – | Sell |
-31,681
| Closed | -$667K | – | 4112 |
|
|
2015
Q2 | $667K | Buy |
+31,681
| New | +$667K | ﹤0.01% | 3248 |
|